153 related articles for article (PubMed ID: 9730150)
21. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
Yamamoto K; Saito K; Takai T; Yoshida S
Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
[TBL] [Abstract][Full Text] [Related]
23. [The role of radiotherapy in Graves' ophthalmopathy].
Jaulerry C
J Fr Ophtalmol; 2004 Sep; 27(7):825-7. PubMed ID: 15499286
[TBL] [Abstract][Full Text] [Related]
24. Investigations of ocular changes, extraocular muscle thickness, and eye movements in Graves' ophthalmopathy.
Jankauskiene J; Imbrasiene D
Medicina (Kaunas); 2006; 42(11):900-3. PubMed ID: 17172791
[TBL] [Abstract][Full Text] [Related]
25. Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response.
Cardoso CC; Giordani AJ; Wolosker AM; Souhami L; Manso PG; Dias RS; Segreto HR; Segreto RA
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1285-91. PubMed ID: 21550180
[TBL] [Abstract][Full Text] [Related]
26. High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy.
Pigeon P; Orgiazzi J; Berthezene F; Gerard JP; Haguenauer JP; Mornex R
Horm Res; 1987; 26(1-4):172-6. PubMed ID: 3110042
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of radiation therapy in the treatment of Graves' orbitopathy.
Matthiesen C; Thompson JS; Thompson D; Farris B; Wilkes B; Ahmad S; Herman T; Bogardus C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):117-23. PubMed ID: 21030157
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of extraocular muscle volume and exophthalmos reduction after radiation therapy to treat Graves' ophthalmopathy: A pilot study.
Kim M; Chang JH; Lee NK
Eur J Ophthalmol; 2021 Mar; 31(2):340-345. PubMed ID: 31496266
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience of radiation therapy for Graves' ophthalmopathy.
Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
[TBL] [Abstract][Full Text] [Related]
30. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment].
Kamoun M; Abid H; Lamine F; Slimane H; Haddad A
Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063
[TBL] [Abstract][Full Text] [Related]
31. A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy.
Johnson KT; Wittig A; Loesch C; Esser J; Sauerwein W; Eckstein AK
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):103-9. PubMed ID: 19865824
[TBL] [Abstract][Full Text] [Related]
32. Correction of restricted extraocular muscle motility in surgical management of strabismus in graves' ophthalmopathy.
Nguyen VT; Park DJ; Levin L; Feldon SE
Ophthalmology; 2002 Feb; 109(2):384-8. PubMed ID: 11825827
[TBL] [Abstract][Full Text] [Related]
33. Motility disturbances in Graves' ophthalmopathy.
de Waard R; Koornneef L; Verbeeten B
Doc Ophthalmol; 1983 Dec; 56(1-2):41-7. PubMed ID: 6689301
[TBL] [Abstract][Full Text] [Related]
34. [Immunosuppressive therapies in patients with Graves' ophthalmopathy].
Wang J; Wang YT; Shao JQ; Wang X; Du H
Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):125-7. PubMed ID: 15059413
[TBL] [Abstract][Full Text] [Related]
35. [Assessment of early immunosuppressive therapy in the prevention of complications of Graves' disease].
Huszno B; Trofimiuk M; Gołkowski F; Plinta T; Szybiński Z
Przegl Lek; 2004; 61(8):868-71. PubMed ID: 15789920
[TBL] [Abstract][Full Text] [Related]
36. Treating severe Graves' ophthalmopathy.
Bartalena L; Marcocci C; Pinchera A
Baillieres Clin Endocrinol Metab; 1997 Oct; 11(3):521-36. PubMed ID: 9532337
[TBL] [Abstract][Full Text] [Related]
37. Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome?
Mourits MP; Koorneef L; van Mourik-Noordenbos AM; van der Meulen-Schot HM; Prummel MF; Wiersinga WM; Berghout A
Br J Ophthalmol; 1990 Aug; 74(8):481-3. PubMed ID: 2390524
[TBL] [Abstract][Full Text] [Related]
38. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
[TBL] [Abstract][Full Text] [Related]
39. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
Mourits MP; Prummel MF; Wiersinga WM; Koornneef L
Clin Endocrinol (Oxf); 1997 Jul; 47(1):9-14. PubMed ID: 9302365
[TBL] [Abstract][Full Text] [Related]
40. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
